Yukihiko Seki

521 total citations
8 papers, 459 citations indexed

About

Yukihiko Seki is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Yukihiko Seki has authored 8 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Cardiology and Cardiovascular Medicine and 3 papers in Immunology. Recurrent topics in Yukihiko Seki's work include Atherosclerosis and Cardiovascular Diseases (3 papers), Nitric Oxide and Endothelin Effects (2 papers) and RNA and protein synthesis mechanisms (2 papers). Yukihiko Seki is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (3 papers), Nitric Oxide and Endothelin Effects (2 papers) and RNA and protein synthesis mechanisms (2 papers). Yukihiko Seki collaborates with scholars based in Japan. Yukihiko Seki's co-authors include Hisashi Kai, Tsutomu Imaizumi, Rei Shibata, Akihiko Yoshimura, Hideo Yasukawa, Tsuyoshi Nagata, Seiya Kato, Minoru Morimatsu, Kozo Kaibuchi and Fumitaka Kuwahara and has published in prestigious journals such as Circulation, Circulation Research and Hypertension.

In The Last Decade

Yukihiko Seki

8 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yukihiko Seki Japan 8 266 119 111 99 61 8 459
Ken Kusaba Japan 9 150 0.6× 121 1.0× 120 1.1× 48 0.5× 72 1.2× 17 391
Yuen‐Jen Chao Taiwan 9 274 1.0× 72 0.6× 103 0.9× 62 0.6× 53 0.9× 9 540
T. Battle France 8 204 0.8× 140 1.2× 119 1.1× 142 1.4× 58 1.0× 13 554
Zhongbiao Wang United States 13 202 0.8× 75 0.6× 129 1.2× 54 0.5× 108 1.8× 27 482
Tina Selle Germany 4 118 0.4× 144 1.2× 205 1.8× 69 0.7× 108 1.8× 5 468
Yoji Taba Japan 12 404 1.5× 72 0.6× 63 0.6× 87 0.9× 60 1.0× 16 698
Zaher Raslan United Kingdom 12 135 0.5× 135 1.1× 107 1.0× 54 0.5× 81 1.3× 13 442
Yasuyuki Onai Japan 6 162 0.6× 154 1.3× 152 1.4× 83 0.8× 68 1.1× 6 447
C. Adamy France 11 207 0.8× 209 1.8× 58 0.5× 60 0.6× 85 1.4× 13 528
Rebecca A. Houliston United Kingdom 9 299 1.1× 83 0.7× 63 0.6× 63 0.6× 44 0.7× 9 534

Countries citing papers authored by Yukihiko Seki

Since Specialization
Citations

This map shows the geographic impact of Yukihiko Seki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yukihiko Seki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yukihiko Seki more than expected).

Fields of papers citing papers by Yukihiko Seki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yukihiko Seki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yukihiko Seki. The network helps show where Yukihiko Seki may publish in the future.

Co-authorship network of co-authors of Yukihiko Seki

This figure shows the co-authorship network connecting the top 25 collaborators of Yukihiko Seki. A scholar is included among the top collaborators of Yukihiko Seki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yukihiko Seki. Yukihiko Seki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Koga, Mitsuhisa, Hisashi Kai, Hideo Yasukawa, et al.. (2007). Postnatal Blocking of Interferon-.GAMMA. Function Prevented Atherosclerotic Plaque Formation in Apolipoprotein E-Knockout Mice. Hypertension Research. 30(3). 259–267. 20 indexed citations
2.
Kusaba, Ken, Hisashi Kai, Mitsuhisa Koga, et al.. (2007). Inhibition of Intrinsic Interferon-γ Function Prevents Neointima Formation After Balloon Injury. Hypertension. 49(4). 909–915. 27 indexed citations
3.
Shibata, Rei, Hisashi Kai, Yukihiko Seki, et al.. (2003). Rho-Kinase Inhibition Reduces Neointima Formation after Vascular Injury by Enhancing Bax Expression and Apoptosis. Journal of Cardiovascular Pharmacology. 42. S43–S47. 36 indexed citations
4.
Shibata, Rei, Hisashi Kai, Yukihiko Seki, et al.. (2003). Inhibition of STAT3 Prevents Neointima Formation by Inhibiting Proliferation and Promoting Apoptosis of Neointimal Smooth Muscle Cells. Human Gene Therapy. 14(7). 601–610. 52 indexed citations
5.
Shibata, Rei, Hisashi Kai, Yukihiko Seki, et al.. (2001). Role of Rho-Associated Kinase in Neointima Formation After Vascular Injury. Circulation. 103(2). 284–289. 113 indexed citations
6.
Seki, Yukihiko, Hisashi Kai, Rei Shibata, et al.. (2000). Role of the JAK/STAT Pathway in Rat Carotid Artery Remodeling After Vascular Injury. Circulation Research. 87(1). 12–18. 118 indexed citations
7.
Seki, Yukihiko, et al.. (1998). Myocardial dna strand breaks are detected in biopsy tissues from patients with dilated cardiomyopathy. Clinical Cardiology. 21(8). 591–596. 14 indexed citations
8.
Kai, Hisashi, Yukihiko Seki, Fumitaka Kuwahara, et al.. (1998). Expression of Proto-oncogenes and Gene Mutation of Sarcomeric Proteins in Patients With Hypertrophic Cardiomyopathy. Circulation Research. 83(6). 594–601. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026